Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80093863

Market status:

Marketed

Licence Status:

Active

Brand name(s):

Heme Iron

Licence holder:

New Roots Herbal Inc.

Dosage Form:

Capsule

Recommended route of administration:

Oral

Recommended use or purpose:

A factor in the maintenance of good health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue.

Risk Information:

Cautions and Warnings 

Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Consult a health-care practitioner prior to use if you have a peptic ulcer, regional enteritis, or ulcerative colitis. Before using heme iron polypeptide, tell your pharmacist or doctor if you are using methyldopa or other iron-containing products. Iron supplements can decrease the absorption of drugs such as tetracycline antibiotics, penicillamine, cefdinir, chloramphenicol, levothyroxine, levodopa, and quinolone antibiotics;. therefore, doses of these medications should be spaced as far as possible. This product may interfere with certain laboratory tests (including testing for blood in stool), possibly causing false test results;make sure laboratory personnel and all doctors know you are taking this product. This product should not be used if you have certain medical conditions. Individuals that have hemochromatosis, other types of anemia, repeated blood transfusions, or stomach/intestinal problems should tell their pharmacist or doctor before using this product. Keep out of reach of children. There is enough drug in this package to seriously harm a child.

Contra-Indications 

A very serious allergic reaction to this product is rare; do not use if you have an allergy to bovine products. Do not lie down for 30 minutes after taking this product.

Known Adverse Reactions 

Constipation, diarrhea, nausea, upset stomach and abdominal cramping may occur. Iron may cause stools to turn black, an effect that is not harmful. Stop use if hypersensitivity occurs

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Folate	333.0 mcg
Iron	11.0 mg
Vitamin B12	333.0 mcg
Vitamin C	90.0 mg

List of non-medicinal ingredients:

• Hypromellose
• Magnesium stearate
• Microcrystalline cellulose
• Purified water
• Silicon dioxide

Date of licensing:

2019-08-09

Revised date of licence:

2024-06-03